CPT code 87637: Description, fee schedule, and billing guide

CPT code 87637 bills a single multiplex amplified probe test that detects SARS-CoV-2, influenza A, influenza B, and RSV from one respiratory specimen. All four targets have to sit on the assay. If the platform skips RSV, 87636 is the correct code, and billing 87637 anyway reads as upcoding.

That one analyte decides whether the claim pays or comes back denied. What follows covers the official scope, the 87636 comparison, and what Medicare pays under the lab fee schedule. Documentation, modifiers, and the errors that trigger denials come after that.

Found our content helpful?

Key takeaways

CPT code 87637 covers one multiplex amplified probe test that detects SARS-CoV-2, influenza A, influenza B, and RSV together.

All four targets must appear on the assay, so a panel without RSV is billed as 87636 instead.

The code sits in the nucleic acid detection family, which rules out antigen tests and lateral-flow rapid tests.

Medicare pays 87637 from the Clinical Laboratory Fee Schedule, so the rate is a flat national figure with no RVU components.

Most denials trace back to code choice, thin medical necessity notes, or a missing CLIA number on the claim.

CPT code 87637 covers four targets, and all four have to be there

CPT code 87637 is a nucleic acid detection code. It describes one multiplex amplified probe test that finds SARS-CoV-2, influenza A, influenza B, and RSV in the same respiratory specimen.

The code sits in the 87xxx infectious agent range and pays from the CMS Clinical Laboratory Fee Schedule (CLFS), not the Medicare Physician Fee Schedule. Annual CLFS updates set the rate, so no RVU calculation comes into it.

All four analytes have to be targeted for 87637 to apply. When the lab platform leaves RSV out, billers use 87636 instead. Claiming 87637 for a three-analyte panel is upcoding, and it can trigger a payer audit.

One analyte is all that separates 87637 from 87636

RSV is the only difference. CPT 87637 carries it as a fourth target, while 87636 covers SARS-CoV-2 and influenza types A and B only. Both codes need a multiplex amplified probe method and a respiratory specimen.

That narrow split causes a large share of respiratory panel coding errors. A practice may run a four-target instrument, then bill the three-target code out of habit.

Here is how the mix-up usually happens. A patient arrives in December with fever and a cough, and the front desk orders the practice’s standard respiratory panel.

The instrument reports four results, RSV included. The charge template still carries 87636 from last season, nobody edits it, and the claim underpays by a full analyte.

So before you choose between the two codes, confirm that the report or the instrument specification names RSV as a target. That record is what supports your code choice if a payer asks later.

Where 87637 sits among the other respiratory panel codes

Four codes cover most respiratory panel billing, and the method separates them first. The decision runs in two steps: check the technique, then read the target list off the report.

Point-of-care testing lands somewhere else entirely. Because 87637 requires amplification, only PCR and similar platforms qualify, and a lateral-flow test never does, however many viruses its packaging names.

Payment comes off the lab fee schedule, not the physician one

Medicare pays 87637 from the Clinical Laboratory Fee Schedule. CMS sets those rates nationally and updates them every year. Since the figure moves annually, take it from the CMS Clinical Laboratory Fee Schedule rather than a third-party aggregator.

Four points shape what 87637 pays:

• CLFS rates are national, and CMS publishes them in the annual CLFS release. The 2026 file is the reference for this year’s figure.
• CLFS codes carry no RVU components. Payment is a flat fee per test, with no facility and non-facility split in most cases.
• Commercial rates vary widely from Medicare. Check the contract, or send each payer a fee schedule inquiry.
• Several payers rewrote their multiplex COVID-19 policies after the pandemic. Verify current coverage instead of assuming the emergency-period rules still stand.

What a payer expects to see behind a four-target panel

A clean 87637 claim has to prove two things. The first is the technique the lab used, and the second is the clinical reason a four-target panel was ordered.

Medicare Administrative Contractors, known as MACs, publish Local Coverage Determinations that define acceptable indications. Requirements differ by jurisdiction, so read your own MAC’s LCD before you submit.

Before you submit: The seven-item check

Run this list against the encounter record rather than against memory.

• Ordering provider: name, NPI, and credentials of the clinician who ordered the test
• Clinical indication: the documented signs, symptoms, or exposure that justified a four-target panel this season
• Specimen details: specimen type, collection date, and collection site
• Assay identification: the test name or platform, showing that all four targets were reported
• ICD-10-CM linkage: at least one valid diagnosis code from the encounter that supports medical necessity
• Ordering date: the date of the order, kept separate from the collection and result dates
• CLIA certification: a valid CLIA certificate for the performing lab, with the number on the claim

How an 87637 claim travels from order to payment

Knowing the path helps you put the check at the right step.

1. The clinician orders the panel, and the indication goes into the encounter note.
2. The lab runs the assay and releases a report naming each target it resolved.
3. Charge capture turns that report into a line item, which is where the wrong code gets picked.
4. The claim leaves as an 837P file, carrying the CLIA number and the diagnosis link.
5. The clearinghouse either rejects it for missing fields or passes it to the payer.
6. The payer pays, denies, or requests records, and the remittance advice says which.

Steps three and four cause most of the damage, and both are checkable before the batch leaves the building. The wider clean claim requirements apply to lab lines exactly as they do to office visits.

Modifiers 59, QW, and 91: When each one earns its place

None of the three is automatic with 87637. Each answers a specific question about the encounter, and the answer has to be in the record.

Check each modifier against your MAC’s LCD or the payer’s own policy before appending it. Adding 59 by reflex is a common audit finding, and QW belongs only on a platform that carries a waiver.

Coverage shifted when the public health emergency ended

Medicare coverage for 87637 runs on CMS guidance plus MAC-issued LCDs. CMS widened multiplex respiratory coverage during the COVID-19 Public Health Emergency. That period has ended, so confirm the current position with your MAC before billing in 2026.

Coverage also splits by payer type:

• Medicare: 87637 has been covered under the CLFS with documented medical necessity. Check the applicable NCD or LCD with your MAC for current criteria.
• Medicaid: coverage varies by state. Medi-Cal published billing guidance covering 87637 during the pandemic period, and DHCS should confirm the current status before you bill.
• Commercial insurers: policies and contracted rates differ widely. Some carriers rewrote their respiratory panel rules after the federal emergency ended, and a few now require prior authorization.

Five errors that turn an 87637 claim into a denial

Most 87637 denials come from five preventable errors. Each one is catchable before the claim batch goes out.

• Wrong code selection. If the lab report does not name RSV, the correct code is 87636. Auditing the report against the billed code is the single best prevention step.
• Thin medical necessity. The note has to record the respiratory symptoms or the exposure that justified a four-target panel during this season.
• Unbundling. Billing 87635 alongside 87637 for one specimen double-counts the SARS-CoV-2 target, and the payer will reject the line.
• Wrong technique. A non-amplified immunoassay does not qualify for 87637, whatever the report headline says. The method has to appear on the report.
• Missing CLIA number. Claims without the performing lab’s CLIA certificate number reject outright, and staff often misread those rejections as coverage denials.

When one does slip through, the remittance advice names the reason. Reading the matching denial codes tells you whether to correct and resubmit or to appeal.

How claims software keeps an 87637 claim moving

In most practices this check happens in someone’s head. A biller reads the analyte list, keys the charge, and the claim joins the next batch. Missing CLIA numbers and lapsed policies travel out with it.

Practice management software like Pabau moves those checks earlier. The claim is built from the charge already sitting in the patient record. The ordering provider, the NPI, and the diagnosis link all travel with it. Required fields get validated before the file is created.

In the US, Pabau connects to the Claim.MD clearinghouse for 837P submission, eligibility checks, and ERA remittance posting. Eligibility can run before the specimen is collected, so a lapsed policy surfaces while the patient is still in the building.

Remittances then post back against the original charge, which keeps the follow-up list short. All of it sits inside Pabau’s claims software for practices, next to the record the charge came from.

Send lab claims without the rework

Pabau builds claims from the charge on the patient record, submits them electronically through Claim.MD, and posts remittances back automatically. See how it handles lab lines like 87637.

Book a demo

Conclusion

The four-analyte rule is the whole code. Read the target list on the report, match it to 87637 or 87636, and most of what goes wrong with these claims never starts.

Put that check in the batching routine rather than the appeals queue. Comparing report to code before submission costs a minute. The same catch after a denial costs a rework, a resubmission, and weeks of waiting for payment.

If lab charges, eligibility checks, and remittances currently live in three separate systems, book a demo and see how one patient record handles all three.

Continue your research

Need to work out why a lab claim came back unpaid? Denial codes in medical billing explains the most common CARC reason codes and how to respond to each.

Want to understand the 837P format used for lab submissions? 837 file billing guide covers the EDI transaction structure payers expect for electronic claims.

Checking coverage before the specimen is collected? Insurance eligibility verification walks through the checks that stop non-covered service denials at the front desk.

Mapping how money reaches the practice? Revenue cycle management sets out each stage from registration to posted payment, including where lab lines differ.

Comparing systems to handle lab billing? Best medical billing software for US practices reviews platforms that support CLFS code submission, eligibility checks, and ERA workflows.

Frequently asked questions